Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

Mitchell R. Smith, Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir S. Parekh, David T. Yang, Eric D. Hsi, Thomas Witzig, Sandeep Dave, David Scott, Curtis Hanson, Lale Kostakoglu Shields, Nizar Abdel-Samad, Carla Casulo, Nancy L. Bartlett, Paolo F. Caimi, Tareq Al Baghdadi, Kristie A. Blum, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl

Open source

DOI: 10.1182/blood.2024023962
Published: 2024-09-05
Container: Blood
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2024023962,
  title = {Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL},
  author = {Mitchell R. Smith and Opeyemi A. Jegede and Peter Martin and Brian G. Till and Samir S. Parekh and David T. Yang and Eric D. Hsi and Thomas Witzig and Sandeep Dave and David Scott and Curtis Hanson and Lale Kostakoglu Shields and Nizar Abdel-Samad and Carla Casulo and Nancy L. Bartlett and Paolo F. Caimi and Tareq Al Baghdadi and Kristie A. Blum and Mark D. Romer and David J. Inwards and Rachel E. Lerner and Lynne I. Wagner and Richard F. Little and Jonathan W. Friedberg and John P. Leonard and Brad S. Kahl},
  year = {2024},
  journal = {Blood},
  doi = {10.1182/blood.2024023962},
  url = {https://doi.org/10.1182/blood.2024023962}
}

RIS

TY  - JOUR
TI  - Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL
AU  - Mitchell R. Smith
AU  - Opeyemi A. Jegede
AU  - Peter Martin
AU  - Brian G. Till
AU  - Samir S. Parekh
AU  - David T. Yang
AU  - Eric D. Hsi
AU  - Thomas Witzig
AU  - Sandeep Dave
AU  - David Scott
AU  - Curtis Hanson
AU  - Lale Kostakoglu Shields
AU  - Nizar Abdel-Samad
AU  - Carla Casulo
AU  - Nancy L. Bartlett
AU  - Paolo F. Caimi
AU  - Tareq Al Baghdadi
AU  - Kristie A. Blum
AU  - Mark D. Romer
AU  - David J. Inwards
AU  - Rachel E. Lerner
AU  - Lynne I. Wagner
AU  - Richard F. Little
AU  - Jonathan W. Friedberg
AU  - John P. Leonard
AU  - Brad S. Kahl
PY  - 2024
JO  - Blood
DO  - 10.1182/blood.2024023962
UR  - https://doi.org/10.1182/blood.2024023962
ER  -

APA

Smith, M. R., Jegede, O. A., Martin, P., Till, B. G., Parekh, S. S., Yang, D. T., Hsi, E. D., Witzig, T., Dave, S., Scott, D., Hanson, C., Shields, L. K., Abdel-Samad, N., Casulo, C., Bartlett, N. L., Caimi, P. F., Baghdadi, T. A., Blum, K. A., Romer, M. D., Inwards, D. J., Lerner, R. E., Wagner, L. I., Little, R. F., Friedberg, J. W., Leonard, J. P., & Kahl, B. S. (2024). Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL. Blood. https://doi.org/10.1182/blood.2024023962

Source records

crossref · retrieved 2026-09-26T12:05:57.090Z